The significance of our findings was highlighted in a retrospective study where we observed that negative correlation existed between the levels of RANBP9 protein expression and response to platinum-based treatment in NSCLC patients[50]. The gene discussed is RANBP9; the disease is non-small cell lung carcinoma.